Quantcast
Last updated on April 24, 2014 at 0:09 EDT

Latest Boehringer Ingelheim Vetmedica Inc. Stories

2014-03-27 23:23:45

Pet Medical Center offers the complete line of new low-dose BI Ultra Duramune canine vaccines with next-generation PureFil technology to provide a more comfortable vaccination experience with fewer side effects to dogs in Temecula CA. Temecula, CA (PRWEB) March 27, 2014 Pet Medical Center, a veterinary hospital in Temecula CA, has long been dedicated to providing the highest standard of care for cats and dogs. Now, with the addition of new low-dose BI Ultra Duramune vaccines to their...

2013-11-07 08:30:41

Boehringer Ingelheim Vetmedica, Inc., (BIVI) launches web-based canine leptospirosis map to inform pet owners of potential disease risks in their area ST. JOSEPH, Mo., Nov. 7, 2013 /PRNewswire/ -- A new interactive map of the United States based on an online survey of veterinarians launched on Leptoinfo.com helps to highlight the risk of leptospirosis (lepto) across the country. (Photo: http://photos.prnewswire.com/prnh/20131107/CG12150) (Logo:...

2013-11-06 12:29:04

New line features an updated equine influenza strain to provide most relevant respiratory protection to horses. ST. JOSEPH, Mo., Nov. 6, 2013 /PRNewswire/ -- Boehringer Ingelheim Vetmedica, Inc. (BIVI), introduces the new Vetera(®) XP line of vaccines, the only vaccine line that contains the most relevant strains of equine influenza virus (EIV) that affect horses today. (Logo: http://photos.prnewswire.com/prnh/20120925/CG80722LOGO) By protecting horses against Richmond/07,...

2013-08-13 08:28:51

Boehringer Ingelheim puts a cutting-edge perspective on vaccines with a revolutionary low-dose vaccine line that improves the overall vaccine experience for dogs. ST. JOSEPH, Mo., Aug. 13, 2013 A new, revolutionary vaccine line is now available that contains the same vaccine protection you've come to expect against deadly pet diseases with 50 percent less volume per dose by using innovative improvements to the manufacturing process. (Photo:...

2012-12-03 16:24:19

ST. JOSEPH, Mo., Dec. 3, 2012 /PRNewswire/ -- Researchers at two universities will be studying equine pigeon fever (Corynebacterium pseudotuberculosis) as recipients of the 2012 Advancement of Equine Research Awards, sponsored by Boehringer Ingelheim Vetmedica, Inc. (BIVI). (Logo: http://photos.prnewswire.com/prnh/20120925/CG80722LOGO) Proposals by Roberta R. Pollock, Ph.D., professor of biology at Occidental College, and Allison J. Stewart, BVSc, professor of equine internal medicine at...

2012-09-25 06:27:41

ST. JOSEPH, Mo., Sept. 25, 2012 /PRNewswire/ -- Boehringer Ingelheim Vetmedica, Inc. (BIVI), announces the addition of more than 75 positions to its U.S. sales force. The expanding animal health company plans to have all sales representatives and professional service veterinarians on board by early January 2013. The addition increases the entire BIVI field force to more than 350. (Logo: http://photos.prnewswire.com/prnh/20120925/CG80722LOGO) The increased sales force will help BIVI...

2012-06-07 10:23:42

ST. JOSEPH, Mo., June 7, 2012 /PRNewswire/ -- Boehringer Ingelheim Vetmedica, Inc. (BIVI) announces LeptoInfo.com has been updated to include new information on the spread of canine leptospirosis (lepto) in the United States and how pet owners can help lower the risks for their dogs. (Photo: http://photos.prnewswire.com/prnh/20120607/CG21089) The website will be available for pet owners on June 1, 2012 in time for late spring and warmer weather when exposure to lepto increases due to...

2012-04-30 14:21:16

ST. JOSEPH, Mo., April 30, 2012 /PRNewswire/ -- Public and private researchers studying Pigeon Fever (Corynebacterium pseudotuberculosis) are invited to submit proposals for the 2012 Equine Research Awards sponsored by Boehringer Ingelheim Vetmedica, Inc. (BIVI). (Logo: http://photos.prnewswire.com/prnh/20120430/CG97792LOGO) Proposals must address one or more specific criteria to be considered: Pathophysiology of Corynebacterium pseudotuberculosis and development of an equine challenge...

2011-06-20 16:42:00

ST. JOSEPH, Mo., June 20, 2011 /PRNewswire/ -- Dog lovers have big hearts. Now they can turn their passion for their pets into action by participating in a program that funds new research for canine heart disease - and perhaps win a vacation at the same time. In the online Million Heart Challenge, as soon as one million visitors click on the website, Boehringer Ingeleheim Vetmedica, Inc. (BIVI), will donate $15,000 to the American College of Internal Veterinary Medicine (ACVIM) to support...

2009-10-26 08:22:00

INGELHEIM, Germany and ST. JOSEPH, Mo., Oct. 26 /PRNewswire/ -- Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced today that it has closed its deal with Pfizer to acquire a significant portion of the Fort Dodge Animal Health business. The acquisition, which includes products in the U.S., Australia, Canada and South Africa, as well as two manufacturing and research facilities...